Pharvaris N.V. Files 6-K, References Jan 22 Press Release

Ticker: PHVS · Form: 6-K · Filed: Jan 22, 2024 · CIK: 1830487

Pharvaris N.V. 6-K Filing Summary
FieldDetail
CompanyPharvaris N.V. (PHVS)
Form Type6-K
Filed DateJan 22, 2024
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: regulatory-filing, press-release, corporate-update

TL;DR

**Pharvaris filed a 6-K, pointing to a press release issued today, so check that for actual news.**

AI Summary

On January 22, 2024, Pharvaris N.V. filed a 6-K report with the SEC, indicating they issued a press release on the same day. This filing is a routine update for foreign private issuers, confirming their ongoing compliance with U.S. securities regulations. For investors, this filing itself doesn't contain new material financial or operational news, but rather points to an external press release that would contain such information, meaning investors need to find that press release for actual news.

Why It Matters

This filing signals that Pharvaris N.V. is actively communicating with the market via a press release, which likely contains important updates for shareholders, but the filing itself is merely a procedural notification.

Risk Assessment

Risk Level: low — This 6-K filing is purely administrative, indicating compliance and referencing an external press release, thus posing no direct risk.

Analyst Insight

An investor should locate and review the press release issued on January 22, 2024, as referenced in this 6-K, to understand any actual material news from Pharvaris N.V.

Key Players & Entities

  • Pharvaris N.V. (company) — the registrant filing the 6-K
  • January 22, 2024 (date) — date of the report and press release
  • 001-40010 (other) — Commission File Number for Pharvaris N.V.

Forward-Looking Statements

  • Pharvaris N.V. will continue to file 6-K reports for material updates as a foreign private issuer. (Pharvaris N.V.) — high confidence, target: ongoing

FAQ

What is the primary purpose of this 6-K filing by Pharvaris N.V.?

The primary purpose of this 6-K filing is to report that Pharvaris N.V. issued a press release on January 22, 2024, which is attached as Exhibit 99.1 to the filing.

When was the press release mentioned in this filing issued?

The press release mentioned in this filing was issued on January 22, 2024, the same date as the 6-K report.

What is Pharvaris N.V.'s Commission File Number?

Pharvaris N.V.'s Commission File Number is 001-40010, as stated in the filing.

Is Pharvaris N.V. filing annual reports under Form 20-F or Form 40-F?

Pharvaris N.V. indicates by check mark that it files annual reports under cover of Form 20-F.

What is the address of Pharvaris N.V.'s principal executive office?

The address of Pharvaris N.V.'s principal executive office is Emmy Noetherweg 2, 2333 BK Leiden, The Netherlands.

Filing Stats: 495 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-01-22 06:51:43

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PHARVARIS N.V. Date: January 22, 2024 By: /s/ Berndt Modig Name: Berndt Modig Title: Chief Executive Officer EXHIBIT INDEX Exhibit No. Description 99.1 Press release, dated January 22, 2024. 99.2 Corporate Presentation, dated January 22, 2024.

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.